Mitigating the Societal and Economic Costs Associated with Opioid Prescribing

This presentation will educate stakeholders within the Pharmacy Benefit Management space on the economics and human costs associated with opioid prescribing.  It will also provide an in-depth look at the most common barriers to the safe initiation, monitoring and discontinuation of opioid therapy. Furthermore, it will offer innovative and actionable solutions, with proven outcomes that can be implemented easily within the workflow of a PBM. 

Attendees will be able to:

  • Discuss the societal and economic costs associated with opioid prescribing
  • Describe barriers to the safe initiation, monitoring and discontinuation of opioid therapy
  • Implement strategies and tools at the PBM level that reduce the societal and economic costs associated with opioid prescribing